Treatment and prevention of osteoporosis

Wiener Medizinische Wochenschrift

Volumn 157, Issue 23-24, 2007, Pages 589-592

  Blahoš, Jaroslav ^a  

^a CENTRAL MILITARY HOSPITAL   (Czech Republic)

Author keywords

Anabolics; Antiresorptives; Basic treatment; Future trends; Mixed effects; Osteoporosis

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM; ESTROGEN; VITAMIN D;

BONE PAIN; CALCIUM ABSORPTION; DRUG EFFICACY; EXERCISE; HORMONE SUBSTITUTION; HUMAN; OSTEOLYSIS; OSTEOPOROSIS; PHYSICAL ACTIVITY; REVIEW; RISK REDUCTION; UTERUS CANCER; VITAMIN SUPPLEMENTATION;

BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; CALCITONIN; CALCIUM, DIETARY; COMBINED MODALITY THERAPY; DIPHOSPHONATES; DRUGS, INVESTIGATIONAL; ESTROGEN REPLACEMENT THERAPY; EXERCISE; HUMANS; ORGANOMETALLIC COMPOUNDS; OSTEOPOROSIS; OSTEOPOROSIS, POSTMENOPAUSAL; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TERIPARATIDE; THIOPHENES; VITAMIN D;

EID: 38049068209     PISSN: 00435341     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10354-007-0486-7     Document Type: Review

References (8)

1. Lee SH, Dargent-Molina P, Bréart G; EPIDOS Group. Epidemiologie de l'Osteoporose Study (2002) Risk factors for fractures of the proximal humerus: results from the EPIDOS prospective study. J Bone Miner Res 17: 817-825
2. Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, Bonds D, Brunner R, Brzyski R, Caan B, Chlebowski R, Curb D, Gass M, Hays J, Heiss G, Hendrix S, Howard BV, Hsia J, Hubbell A, Jackson R, Johnson KC, Judd H, Kotchen JM, Kuller L, LaCroix AZ, Lane D, Langer RD, Lasser N, Lewis CE, Manson J, Margolis K, Ockene J, O'Sullivan MJ, Phillips L, Prentice RL, Ritenbaugh C, Robbins J, Rossouw JE, Sarto G, Stefanick ML, Van Horn L, Wactawski-Wende J, Wallace R, Wassertheil-Smoller S; Women's Health Initiative Steering Committee The Women's Health Initiative Steering Committee (2004) Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 291: 1701-1712
3. Barrett-Connor E, Mosca L, Collins P, Geiger MJ, Grady D, Kornitzer M, McNabb MA, Wenger NK; Raloxifene Use for The Heart (RUTH) Trial Investigators (2006) Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women. N Engl J Med 355: 125-137
4. Miller PD, McClung MR, Macovei L, Stakkestad JA, Luckey M, Bonvoisin B, Reginster JY, Recker RR, Hughes C, Lewiecki EM, Felsenberg D, Delmas PD, Kendler DL, Bolognese MA, Mairon N, Cooper C (2005) Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study. J Bone Miner Res 20: 1315-1322
5. Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, Cauley JA, Cosman F, Lakatos P, Leung PC, Man Z, Mautalen C, Mesenbrink P, Hu H, Caminis J, Tong K, Rosario-Jansen T, Krasnow J, Hue TF, Sellmeyer D, Eriksen EF, Cummings SR; HORIZON Pivotal Fracture Trial (2007) Once-yearly zoledronic acid for treatment of post-menopausal osteoporosis. N Engl J Med 356: 1809-1822
6. Bilezikian JP (2006) Osteonecrosis of the jaw - do bisphosphonates pose a risk? N Engl J Med 355: 2278-2281
7. Marie PJ (2006) Strontium ranelate: a dual mode of action rebalancing bone turnover in favour of bone formation. Curr Opin Rheumatol 18(Suppl 1): S11-S15
8. McClung MR, Lewiecki EM, Cohen SB, Bolognese MA, Woodson GC, Moffett AH, Peacock M, Miller PD, Lederman SN, Chesnut CH, Lain D, Kivitz AJ, Holloway DL, Zhang C, Peterson MC, Bekker PJ; AMG 162 Bone Loss Study Group (2006) Denosumab in postmenopausal women with low bone mineral density. N Engl J Med 354: 821-831